Results showed that the FXR KO cells had enhanced cell proliferation and tumorigenic ability in vivo compared to the control (Figure 5A), the final tumor size, weight, and tumor growth of HBx C40 overexpressing FXR KO cells were greater than those of the FXR KO control (Figure 5B,C). This evidence concerns the gene NR1H4 and neoplasm.